1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Inactivated Poliovirus Vaccine Revenue
1.4 Market Analysis by Type
1.4.1 Global Inactivated Poliovirus Vaccine Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Human Diploid Cell
1.4.3 Monkey Kidney Cell
1.5 Market by Application
1.5.1 Global Inactivated Poliovirus Vaccine Market Share by Application: 2021-2026
1.5.2 Public
1.5.3 Private
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Inactivated Poliovirus Vaccine Market
1.8.1 Global Inactivated Poliovirus Vaccine Market Status and Outlook (2015-2026)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Inactivated Poliovirus Vaccine Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global Inactivated Poliovirus Vaccine Revenue Market Share by Manufacturers (2015-2020)
2.3 Global Inactivated Poliovirus Vaccine Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Inactivated Poliovirus Vaccine Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Inactivated Poliovirus Vaccine Sales Volume Market Share by Region (2015-2020)
3.2 Global Inactivated Poliovirus Vaccine Sales Revenue Market Share by Region (2015-2020)
3.3 North America Inactivated Poliovirus Vaccine Sales Volume
3.3.1 North America Inactivated Poliovirus Vaccine Sales Volume Growth Rate (2015-2020)
3.3.2 North America Inactivated Poliovirus Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 East Asia Inactivated Poliovirus Vaccine Sales Volume
3.4.1 East Asia Inactivated Poliovirus Vaccine Sales Volume Growth Rate (2015-2020)
3.4.2 East Asia Inactivated Poliovirus Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe Inactivated Poliovirus Vaccine Sales Volume (2015-2020)
3.5.1 Europe Inactivated Poliovirus Vaccine Sales Volume Growth Rate (2015-2020)
3.5.2 Europe Inactivated Poliovirus Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 South Asia Inactivated Poliovirus Vaccine Sales Volume (2015-2020)
3.6.1 South Asia Inactivated Poliovirus Vaccine Sales Volume Growth Rate (2015-2020)
3.6.2 South Asia Inactivated Poliovirus Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Southeast Asia Inactivated Poliovirus Vaccine Sales Volume (2015-2020)
3.7.1 Southeast Asia Inactivated Poliovirus Vaccine Sales Volume Growth Rate (2015-2020)
3.7.2 Southeast Asia Inactivated Poliovirus Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Middle East Inactivated Poliovirus Vaccine Sales Volume (2015-2020)
3.8.1 Middle East Inactivated Poliovirus Vaccine Sales Volume Growth Rate (2015-2020)
3.8.2 Middle East Inactivated Poliovirus Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Africa Inactivated Poliovirus Vaccine Sales Volume (2015-2020)
3.9.1 Africa Inactivated Poliovirus Vaccine Sales Volume Growth Rate (2015-2020)
3.9.2 Africa Inactivated Poliovirus Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Oceania Inactivated Poliovirus Vaccine Sales Volume (2015-2020)
3.10.1 Oceania Inactivated Poliovirus Vaccine Sales Volume Growth Rate (2015-2020)
3.10.2 Oceania Inactivated Poliovirus Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 South America Inactivated Poliovirus Vaccine Sales Volume (2015-2020)
3.11.1 South America Inactivated Poliovirus Vaccine Sales Volume Growth Rate (2015-2020)
3.11.2 South America Inactivated Poliovirus Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 Rest of the World Inactivated Poliovirus Vaccine Sales Volume (2015-2020)
3.12.1 Rest of the World Inactivated Poliovirus Vaccine Sales Volume Growth Rate (2015-2020)
3.12.2 Rest of the World Inactivated Poliovirus Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4 North America
4.1 North America Inactivated Poliovirus Vaccine Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Inactivated Poliovirus Vaccine Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Inactivated Poliovirus Vaccine Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Inactivated Poliovirus Vaccine Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Inactivated Poliovirus Vaccine Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Inactivated Poliovirus Vaccine Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Inactivated Poliovirus Vaccine Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Inactivated Poliovirus Vaccine Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Inactivated Poliovirus Vaccine Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Inactivated Poliovirus Vaccine Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Inactivated Poliovirus Vaccine Sales Volume Market Share by Type (2015-2020)
14.2 Global Inactivated Poliovirus Vaccine Sales Revenue Market Share by Type (2015-2020)
14.3 Global Inactivated Poliovirus Vaccine Sales Price by Type (2015-2020)
15 Consumption Analysis by Application
15.1 Global Inactivated Poliovirus Vaccine Consumption Volume by Application (2015-2020)
15.2 Global Inactivated Poliovirus Vaccine Consumption Value by Application (2015-2020)
16 Company Profiles and Key Figures in Inactivated Poliovirus Vaccine Business
16.1 Sanofi
16.1.1 Sanofi Company Profile
16.1.2 Sanofi Inactivated Poliovirus Vaccine Product Specification
16.1.3 Sanofi Inactivated Poliovirus Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.2 IMBCA
16.2.1 IMBCA Company Profile
16.2.2 IMBCA Inactivated Poliovirus Vaccine Product Specification
16.2.3 IMBCA Inactivated Poliovirus Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.3 GSK
16.3.1 GSK Company Profile
16.3.2 GSK Inactivated Poliovirus Vaccine Product Specification
16.3.3 GSK Inactivated Poliovirus Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.4 Serum Institute (Bilthoven Biologicals)
16.4.1 Serum Institute (Bilthoven Biologicals) Company Profile
16.4.2 Serum Institute (Bilthoven Biologicals) Inactivated Poliovirus Vaccine Product Specification
16.4.3 Serum Institute (Bilthoven Biologicals) Inactivated Poliovirus Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
17 Inactivated Poliovirus Vaccine Manufacturing Cost Analysis
17.1 Inactivated Poliovirus Vaccine Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Inactivated Poliovirus Vaccine
17.4 Inactivated Poliovirus Vaccine Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Inactivated Poliovirus Vaccine Distributors List
18.3 Inactivated Poliovirus Vaccine Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Inactivated Poliovirus Vaccine (2021-2026)
20.2 Global Forecasted Revenue of Inactivated Poliovirus Vaccine (2021-2026)
20.3 Global Forecasted Price of Inactivated Poliovirus Vaccine (2015-2026)
20.4 Global Forecasted Production of Inactivated Poliovirus Vaccine by Region (2021-2026)
20.4.1 North America Inactivated Poliovirus Vaccine Production, Revenue Forecast (2021-2026)
20.4.2 East Asia Inactivated Poliovirus Vaccine Production, Revenue Forecast (2021-2026)
20.4.3 Europe Inactivated Poliovirus Vaccine Production, Revenue Forecast (2021-2026)
20.4.4 South Asia Inactivated Poliovirus Vaccine Production, Revenue Forecast (2021-2026)
20.4.5 Southeast Asia Inactivated Poliovirus Vaccine Production, Revenue Forecast (2021-2026)
20.4.6 Middle East Inactivated Poliovirus Vaccine Production, Revenue Forecast (2021-2026)
20.4.7 Africa Inactivated Poliovirus Vaccine Production, Revenue Forecast (2021-2026)
20.4.8 Oceania Inactivated Poliovirus Vaccine Production, Revenue Forecast (2021-2026)
20.4.9 South America Inactivated Poliovirus Vaccine Production, Revenue Forecast (2021-2026)
20.4.10 Rest of the World Inactivated Poliovirus Vaccine Production, Revenue Forecast (2021-2026)
20.5 Forecast by Type and by Application (2021-2026)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
20.5.2 Global Forecasted Consumption of Inactivated Poliovirus Vaccine by Application (2021-2026)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Inactivated Poliovirus Vaccine by Country
21.2 East Asia Market Forecasted Consumption of Inactivated Poliovirus Vaccine by Country
21.3 Europe Market Forecasted Consumption of Inactivated Poliovirus Vaccine by Countriy
21.4 South Asia Forecasted Consumption of Inactivated Poliovirus Vaccine by Country
21.5 Southeast Asia Forecasted Consumption of Inactivated Poliovirus Vaccine by Country
21.6 Middle East Forecasted Consumption of Inactivated Poliovirus Vaccine by Country
21.7 Africa Forecasted Consumption of Inactivated Poliovirus Vaccine by Country
21.8 Oceania Forecasted Consumption of Inactivated Poliovirus Vaccine by Country
21.9 South America Forecasted Consumption of Inactivated Poliovirus Vaccine by Country
21.10 Rest of the world Forecasted Consumption of Inactivated Poliovirus Vaccine by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer